References
- ItoAShinkaiMHondaHKobayashiTMedical application of functionalized magnetic nanoparticlesJ Biosci Bioeng2005100111116233845
- HuberDLSynthesis, properties, and applications of iron nanoparticlesSmall20051548250117193474
- GuptaAKGuptaMSynthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials200526183995402115626447
- HautotDPankhurstQAMorrisCMCurtisABurnJDobsonJPreliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patientsBiochim Biophys Acta200717721212517097860
- LiuGMenPHarrisPLRolstonRKPerryGSmithMANanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalanceNeurosci Lett2006406318919316919875
- BulteJWDouglasTWitwerBMagnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cellsNat Biotechnol200119121141114711731783
- HammBStaksTTaupitzMContrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superpara-magnetic iron oxideJ Magn Reson Imaging1994456596687981510
- VoglTJHammerstinglRPegiosWThe value of the livers-pecific superparamagnetic contrast medium AMI-25 for the detection and differential diagnosis of primary liver tumors versus metastasesRofo19941604319328 German8161744
- JosephsonLLewisJJacobsPHahnPFStarkDDThe effects of iron oxides on proton relaxivityMagn Reson Imaging1988666476532850434
- McLachlanSJMorrisMRLucasMAPhase I clinical evaluation of a new iron oxide MR contrast agentJ Magn Reson Imaging1994433013078061425
- ReimerPMullerMMarxCT1 effects of a bolus-injectable super-paramagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration – preliminary clinical experience with dynamic T1-weighted MR imagingRadiology199820938318369844683
- WangJChenYChenBPharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in miceInt J Nanomedicine2010586186621042548
- LunovOSyrovetsTBucheleBThe effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophagesBiomaterials201031195063507120381862
- HsiaoJKChuHHWangYHMacrophage physiological function after superparamagnetic iron oxide labelingNMR Biomed200821882082918470957
- ParkEJKimHKimYYiJChoiKParkKInflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in miceToxicology20102751–3657120540983
- ChenBAJinNWangJThe effect of magnetic nanoparticles of Fe(3)O(4) on immune function in normal ICR miceInt J Nanomedicine2010559359920856834
- WangJChenBJinNThe changes of T lymphocytes and cytokines in ICR mice fed with Fe3O4 magnetic nanoparticlesInt J Nanomedicine2011660561021674017
- ShenCCLiangHJWangCCLiaoMHJanTRA role of cellular glutathione in the differential effects of iron oxide nanoparticles on antigen-specific T cell cytokine expressionInt J Nanomedicine201162791279822114506
- ShenCCWangCCLiaoMHJanTRA single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB/c miceInt J Nanomedicine201161229123521753874
- CherDJMosmannTRTwo types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clonesJ Immunol198713811368836942953788
- MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–255636606682
- JanTRSuSTWuHYLiaoMHSuppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c miceInt Immunopharmacol20077677378017466911
- BlankFGerberPRothen-RutishauserBBiomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cellsNanotoxicology20115460662121231795
- NaqviSSamimMAbdinMConcentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stressInt J Nanomedicine2010598398921187917
- ReimerPBalzerTFerucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applicationsEur Radiol20031361266127612764641
- Resovist® [package insert]BerlinBayer Schering Pharma AG2002
- ZhuMTFengWYWangBComparative study of pulmonary responses to nano- and submicron-sized ferric oxide in ratsToxicology20082472–310211118394769
- KobayashiKKanedaKKasamaTImmunopathogenesis of delayed-type hypersensitivityMicrosc Res Tech200153424124511340669
- YamashitaKSakaiMTakemotoNAttenuation of delayed-type hypersensitivity by fullerene treatmentToxicology20092611–2192419376187